(R)-4-Acetyl-1-(4-chloro-2-fluorophenyl)-5-cyclohexyl-3-hydroxy-1H-pyrrol-2(5H)-one - CAS 512177-83-2
Catalog: |
BB027370 |
Product Name: |
(R)-4-Acetyl-1-(4-chloro-2-fluorophenyl)-5-cyclohexyl-3-hydroxy-1H-pyrrol-2(5H)-one |
CAS: |
512177-83-2 |
Synonyms: |
(2R)-3-acetyl-1-(4-chloro-2-fluorophenyl)-2-cyclohexyl-4-hydroxy-2H-pyrrol-5-one; (2R)-3-acetyl-1-(4-chloro-2-fluorophenyl)-2-cyclohexyl-4-hydroxy-2H-pyrrol-5-one |
IUPAC Name: | (2R)-3-acetyl-1-(4-chloro-2-fluorophenyl)-2-cyclohexyl-4-hydroxy-2H-pyrrol-5-one |
Description: | (R)-4-Acetyl-1-(4-chloro-2-fluorophenyl)-5-cyclohexyl-3-hydroxy-1H-pyrrol-2(5H)-one (CAS# 512177-83-2) is an allosteric antagonist of the C-C chemokine receptor type 2 (CCR2) with an IC50 of 103 nM. |
Molecular Weight: | 351.80 |
Molecular Formula: | C18H19ClFNO3 |
Canonical SMILES: | CC(=O)C1=C(C(=O)N(C1C2CCCCC2)C3=C(C=C(C=C3)Cl)F)O |
InChI: | InChI=1S/C18H19ClFNO3/c1-10(22)15-16(11-5-3-2-4-6-11)21(18(24)17(15)23)14-8-7-12(19)9-13(14)20/h7-9,11,16,23H,2-6H2,1H3/t16-/m1/s1 |
InChI Key: | VQNLJXWZGVRLBA-MRXNPFEDSA-N |
Boiling Point: | 482.6 °C at 760 mmHg |
Purity: | 98 % |
Density: | 1.383 g/cm3 |
LogP: | 4.24070 |
Publication Number | Title | Priority Date |
CA-2463198-A1 | Pyrrolidinone derivatives | 20011003 |
CZ-2004442-A3 | Pyrrolidinone derivatives | 20011003 |
HU-0402503-A2 | Pyrrolidinone derivatives and pharmaceutical compositions containing the compounds | 20011003 |
JP-2005523238-A | Pyrrolidinone derivative | 20011003 |
KR-20040048936-A | Pyrrolidinone derivatives | 20011003 |
PMID | Publication Date | Title | Journal |
32020584 | 20200501 | The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology | Immunology |
31742400 | 20191226 | Synthesis and Pharmacological Evaluation of Triazolopyrimidinone Derivatives as Noncompetitive, Intracellular Antagonists for CC Chemokine Receptors 2 and 5 | Journal of medicinal chemistry |
27926736 | 20161215 | Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists | Nature |
25772168 | 20150101 | CCL2-CCR2 Signaling in Disease Pathogenesis | Endocrine, metabolic & immune disorders drug targets |
Complexity: | 559 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 1 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 351.1037493 |
Formal Charge: | 0 |
Heavy Atom Count: | 24 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 351.1037493 |
Rotatable Bond Count: | 3 |
Topological Polar Surface Area: | 57.6 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 4.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS